Malvinder Mohan Singh is an Indian businessman with the Fortis health care, Ranbaxy and Religare business. He is a former chairman and CEO of Ranbaxy Laboratories, an Indian unit of Japanese drugmaker Daiichi Sankyo, who resigned in 2009 after Ranbaxy posted losses and after Daiichi Sankyo decided to get more actively involved in the newly acquired Indian unit.